Cargando…
MmpL3 Inhibition: A New Approach to Treat Nontuberculous Mycobacterial Infections
Outside of Mycobacterium tuberculosis and Mycobacterium leprae, nontuberculous mycobacteria (NTM) are environmental mycobacteria (>190 species) and are classified as slow- or rapid-growing mycobacteria. Infections caused by NTM show an increased incidence in immunocompromised patients and patient...
Autores principales: | Sethiya, Jigar P., Sowards, Melanie A., Jackson, Mary, North, Elton Jeffrey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503588/ https://www.ncbi.nlm.nih.gov/pubmed/32867307 http://dx.doi.org/10.3390/ijms21176202 |
Ejemplares similares
-
MmpL3 as a Target for the Treatment of Drug-Resistant Nontuberculous Mycobacterial Infections
por: Li, Wei, et al.
Publicado: (2018) -
Direct Inhibition of MmpL3 by Novel Antitubercular
Compounds
por: Li, Wei, et al.
Publicado: (2019) -
Synergistic Interactions of MmpL3 Inhibitors with Antitubercular Compounds In Vitro
por: Li, Wei, et al.
Publicado: (2017) -
Two-Way Regulation of MmpL3 Expression Identifies
and Validates Inhibitors of MmpL3 Function in Mycobacterium
tuberculosis
por: Grover, Shipra, et al.
Publicado: (2020) -
The driving force for mycolic acid export by mycobacterial MmpL3 is proton translocation
por: Parish, Tanya
Publicado: (2022)